1
|
Klasinc R, Reiter M, Digruber A, Tschulenk W, Walter I, Kirschner A, Spittler A, Stockinger H. A Novel Flow Cytometric Approach for the Quantification and Quality Control of Chlamydia trachomatis Preparations. Pathogens 2021; 10:1617. [PMID: 34959572 PMCID: PMC8706156 DOI: 10.3390/pathogens10121617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2021] [Revised: 12/07/2021] [Accepted: 12/09/2021] [Indexed: 11/27/2022] Open
Abstract
Chlamydia trachomatis is an obligate intracellular pathogenic bacterium with a biphasic developmental cycle manifesting two distinct morphological forms: infectious elementary bodies (EBs) and replicative intracellular reticulate bodies (RBs). Current standard protocols for quantification of the isolates assess infectious particles by titering inclusion-forming units, using permissive cell lines, and analyzing via immunofluorescence. Enumeration of total particle counts is achieved by counting labeled EBs/RBs using a fluorescence microscope. Both methods are time-consuming with a high risk of observer bias. For a better assessment of C. trachomatis preparations, we developed a simple and time-saving flow cytometry-based workflow for quantifying small particles, such as EBs with a size of 300 nm. This included optimization of gain and threshold settings with the addition of a neutral density filter for small-particle discrimination. The nucleic acid dye SYBR® Green I (SGI) was used together with propidium iodide and 5(6)-carboxyfluorescein diacetate to enumerate and discriminate between live and dead bacteria. We found no significant differences between the direct particle count of SGI-stained C. trachomatis preparations measured by microscopy or flow cytometry (p > 0.05). Furthermore, we completed our results by introducing a cell culture-independent viability assay. Our measurements showed very good reproducibility and comparability to the existing state-of-the-art methods, indicating that the evaluation of C. trachomatis preparations by flow cytometry is a fast and reliable method. Thus, our method facilitates an improved assessment of the quality of C. trachomatis preparations for downstream applications.
Collapse
Affiliation(s)
- Romana Klasinc
- Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria; (M.R.); (A.K.); (H.S.)
| | - Michael Reiter
- Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria; (M.R.); (A.K.); (H.S.)
| | - Astrid Digruber
- Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria;
| | - Waltraud Tschulenk
- Institute of Morphology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria; (W.T.); (I.W.)
| | - Ingrid Walter
- Institute of Morphology, Department of Pathobiology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria; (W.T.); (I.W.)
| | - Alexander Kirschner
- Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria; (M.R.); (A.K.); (H.S.)
- Division Water Quality & Health, Department Pharmacology, Physiology and Microbiology, Karl Landsteiner University of Health Sciences, 3500 Krems, Austria
| | - Andreas Spittler
- Core Facility Flow Cytometry and Department of Surgery, Research Laboratories, Medical University of Vienna, 1090 Vienna, Austria;
| | - Hannes Stockinger
- Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria; (M.R.); (A.K.); (H.S.)
| |
Collapse
|
2
|
Skilton RJ, O'Neill C, Thomson NR, Lampe DJ, Clarke IN. Progress towards an inducible, replication-proficient transposon delivery vector for Chlamydia trachomatis. Wellcome Open Res 2021; 6:82. [PMID: 33997299 PMCID: PMC8097735 DOI: 10.12688/wellcomeopenres.16665.1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/26/2021] [Indexed: 11/25/2022] Open
Abstract
Background Genetic systems have been developed for Chlamydia but the extremely low transformation frequency remains a significant bottleneck. Our goal is to develop a self-replicating transposon delivery vector for C. trachomatis which can be expanded prior to transposase induction. Methods We made E. coli/ C. trachomatis shuttle vectors bearing the Himar1 C9 transposase under control of the tet promoter and a novel rearrangement of the Himar1 transposon with the β-lactamase gene. Activity of the transposase was monitored by immunoblot and by DNA sequencing. Results We constructed pSW2-mCh-C9, a C. trachomatis plasmid designed to act as a self-replicating vector carrying both the Himar1 C9 transposase under tet promoter control and its transposon. However, we were unable to recover this plasmid in C. trachomatis following multiple attempts at transformation. Therefore, we assembled two new deletion plasmids pSW2-mCh-C9-ΔTpon carrying only the Himar1 C9 transposase (under tet promoter control) and a sister vector (same sequence backbone) pSW2-mCh-C9-ΔTpase carrying its cognate transposon. We demonstrated that the biological components that make up both pSW2-mCh-C9-ΔTpon and pSW2-mCh-C9-ΔTpase are active in E. coli. Both these plasmids could be independently recovered in C. trachomatis. We attempted to perform lateral gene transfer by transformation and mixed infection with C. trachomatis strains bearing pSW2-mCh-C9-ΔTpon and pSW2-RSGFP-Tpon (a green fluorescent version of pSW2-mCh-C9-ΔTpase). Despite success in achieving mixed infections, it was not possible to recover progeny bearing both versions of these plasmids. Conclusions We have designed a self-replicating plasmid vector pSW2-mCh-C9 for C. trachomatis carrying the Himar1 C9 transposase under tet promoter control. Whilst this can be transformed into E. coli it cannot be recovered in C. trachomatis. Based on selected deletions and phenotypic analyses we conclude that low level expression from the tet inducible promoter is responsible for premature transposition and hence plasmid loss early on in the transformation process.
Collapse
Affiliation(s)
- Rachel J. Skilton
- Molecular Microbiology Group, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK
| | - Colette O'Neill
- Molecular Microbiology Group, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK
| | - Nicholas R. Thomson
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambs, CB10 1RQ, UK
- London School of Hygiene and Tropical Medicine, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
| | - David J. Lampe
- Department of Biological Sciences, Duquesne University, 600 Forbes Ave., Pittsburgh, Pennsylvania, 15116, USA
| | - Ian N. Clarke
- Molecular Microbiology Group, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK
| |
Collapse
|
3
|
Jones CA, Hadfield J, Thomson NR, Cleary DW, Marsh P, Clarke IN, O’Neill CE. The Nature and Extent of Plasmid Variation in Chlamydia trachomatis. Microorganisms 2020; 8:microorganisms8030373. [PMID: 32155798 PMCID: PMC7143637 DOI: 10.3390/microorganisms8030373] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Revised: 03/02/2020] [Accepted: 03/03/2020] [Indexed: 01/03/2023] Open
Abstract
Chlamydia trachomatis is an obligate intracellular pathogen of humans, causing both the sexually transmitted infection, chlamydia, and the most common cause of infectious blindness, trachoma. The majority of sequenced C. trachomatis clinical isolates carry a 7.5-Kb plasmid, and it is becoming increasingly evident that this is a key determinant of pathogenicity. The discovery of the Swedish New Variant and the more recent Finnish variant highlight the importance of understanding the natural extent of variation in the plasmid. In this study we analysed 524 plasmid sequences from publicly available whole-genome sequence data. Single nucleotide polymorphisms (SNP) in each of the eight coding sequences (CDS) were identified and analysed. There were 224 base positions out of a total 7550 bp that carried a SNP, which equates to a SNP rate of 2.97%, nearly three times what was previously calculated. After normalising for CDS size, CDS8 had the highest SNP rate at 3.97% (i.e., number of SNPs per total number of nucleotides), whilst CDS6 had the lowest at 1.94%. CDS5 had the highest total number of SNPs across the 524 sequences analysed (2267 SNPs), whereas CDS6 had the least SNPs with only 85 SNPs. Calculation of the genetic distances identified CDS6 as the least variable gene at the nucleotide level (d = 0.001), and CDS5 as the most variable (d = 0.007); however, at the amino acid level CDS2 was the least variable (d = 0.001), whilst CDS5 remained the most variable (d = 0.013). This study describes the largest in-depth analysis of the C. trachomatis plasmid to date, through the analysis of plasmid sequence data mined from whole genome sequences spanning 50 years and from a worldwide distribution, providing insights into the nature and extent of existing variation within the plasmid as well as guidance for the design of future diagnostic assays. This is crucial at a time when single-target diagnostic assays are failing to detect natural mutants, putting those infected at risk of a serious long-term and life-changing illness.
Collapse
Affiliation(s)
- Charlotte A. Jones
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO166YD, UK; (C.A.J.); (D.W.C.); (I.N.C.)
| | - James Hadfield
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA;
| | - Nicholas R. Thomson
- Pathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK;
| | - David W. Cleary
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO166YD, UK; (C.A.J.); (D.W.C.); (I.N.C.)
| | - Peter Marsh
- Public Health England, Porton Down, Wiltshire SP40JG, UK;
| | - Ian N. Clarke
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO166YD, UK; (C.A.J.); (D.W.C.); (I.N.C.)
| | - Colette E. O’Neill
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO166YD, UK; (C.A.J.); (D.W.C.); (I.N.C.)
- Correspondence:
| |
Collapse
|
4
|
O'Neill CE, Skilton RJ, Pearson SA, Filardo S, Andersson P, Clarke IN. Genetic Transformation of a C. trachomatis Ocular Isolate With the Functional Tryptophan Synthase Operon Confers an Indole-Rescuable Phenotype. Front Cell Infect Microbiol 2018; 8:434. [PMID: 30619780 PMCID: PMC6302012 DOI: 10.3389/fcimb.2018.00434] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Accepted: 11/30/2018] [Indexed: 11/13/2022] Open
Abstract
Chlamydia trachomatis is the leading cause of preventable blindness and the most common bacterial sexually transmitted infection. Different strains are associated with ocular or urogenital infections, and a proposed mechanism that may explain this tissue tropism is the active tryptophan biosynthesis pathway encoded by the genomic trpRBA operon in urogenital strains. Here we describe genetic complementation studies that are essential to confirm the role of tryptophan synthase in the context of an ocular C. trachomatis genomic background. Ocular strain A2497 was transformed with the (urogenital) pSW2::GFP shuttle vector showing that there is no strain tropism barrier to this plasmid vector; moreover, transformation had no detrimental effect on the growth kinetics of A2497, which is important given the low transformation efficiency of C. trachomatis. A derivative of the pSW2::GFP vector was used to deliver the active tryptophan biosynthesis genes from a urogenital strain of C. trachomatis (Soton D1) to A2497 with the aim of complementing the truncated trpA gene common to most ocular strains. After confirmation of intact TrpA protein expression in the transformed A2497, the resulting transformants were cultivated in tryptophan-depleted medium with and without indole or tryptophan, showing that complementation of the truncated trpA gene by the intact and functional urogenital trpRBA operon was sufficient to bestow an indole rescuable phenotype upon A2497. This study proves that pSW2::GFP derived vectors do not conform to the cross-strain transformation barrier reported for other chlamydia shuttle vectors, suggesting these as a universal vector for transformation of all C. trachomatis strains. This vector promiscuity enabled us to test the indole rescue hypothesis by transforming ocular strain A2497 with the functional urogenital trpRBA operon, which complemented the non-functional tryptophan synthase. These data confirm that the trpRBA operon is necessary and sufficient for chlamydia to survive in tryptophan-limited environments such as the female urogenital tract.
Collapse
Affiliation(s)
- Colette Elizabeth O'Neill
- Molecular Microbiology Group, Department of Clinical and Experimental Science, Southampton General Hospital, University Medical School, Southampton, United Kingdom
| | - Rachel Jane Skilton
- Molecular Microbiology Group, Department of Clinical and Experimental Science, Southampton General Hospital, University Medical School, Southampton, United Kingdom
| | - Sarah Ann Pearson
- Molecular Microbiology Group, Department of Clinical and Experimental Science, Southampton General Hospital, University Medical School, Southampton, United Kingdom
| | - Simone Filardo
- Section of Microbiology, Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy
| | - Patiyan Andersson
- Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia
| | - Ian Nicholas Clarke
- Molecular Microbiology Group, Department of Clinical and Experimental Science, Southampton General Hospital, University Medical School, Southampton, United Kingdom
| |
Collapse
|
5
|
Skilton RJ, Wang Y, O'Neill C, Filardo S, Marsh P, Bénard A, Thomson NR, Ramsey KH, Clarke IN. The Chlamydia muridarum plasmid revisited : new insights into growth kinetics. Wellcome Open Res 2018; 3:25. [PMID: 29657985 PMCID: PMC5871946 DOI: 10.12688/wellcomeopenres.13905.1] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/02/2018] [Indexed: 11/23/2022] Open
Abstract
Background: Research in chlamydial genetics is challenging because of its obligate intracellular developmental cycle.
In vivo systems exist that allow studies of different aspects of basic biology of chlamydiae, the murine
Chlamydia muridarum model is one of great importance and thus an essential research tool.
C. muridarum carries a plasmid that has a role in virulence. Our aim was to compare and contrast the
C. muridarum plasmid-free phenotype with that of a chromosomally isogenic plasmid-bearing strain, through the inclusion phase of the developmental cycle. Methods: We measured infectivity for plasmid bearing and plasmid-cured
C. muridarum by inclusion forming assays in McCoy cells and in parallel bacterial chromosome replication by quantitative PCR, throughout the developmental cycle. In addition to these studies, we have carefully monitored chlamydial inclusion formation by confocal microscopy and transmission electron microscopy. A new
E.coli/chlamydial shuttle vector (pNigg::GFP) was constructed using standard cloning technology and used to transform
C. muridarum for further phenotypic studies. Results: We have advanced the definition of the chlamydial phenotype away from the simple static observation of mature inclusions and redefined the
C. muridarum plasmid-based phenotype on growth profile and inclusion morphology. Our observations on the growth properties of plasmid-cured
C. muridarum challenge the established interpretations, especially with regard to inclusion growth kinetics. Introduction of the shuttle plasmid pNigg::GFP into plasmid-cured
C. muridarum restored the wild-type plasmid-bearing phenotype and confirmed that loss of the plasmid was the sole cause for the changes in growth and chromosomal replication. Conclusions: Accurate growth curves and sampling at multiple time points throughout the developmental cycle is necessary to define plasmid phenotypes. There are subtle but important (previously unnoticed) differences in the overall growth profile of plasmid-bearing and plasmid-free
C. muridarum. We have proven that the differences described are solely due to the plasmid pNigg.
Collapse
Affiliation(s)
- Rachel J Skilton
- Molecular Microbiology Group, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK
| | - Yibing Wang
- Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA
| | - Colette O'Neill
- Molecular Microbiology Group, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK
| | - Simone Filardo
- Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University, Rome, Italy
| | - Peter Marsh
- Public Health England, Public Health Laboratory Southampton, Southampton General Hospital, Southampton, UK
| | - Angèle Bénard
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK
| | - Nicholas R Thomson
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.,London School of Hygiene and Tropical Medicine, London, UK
| | - Kyle H Ramsey
- Department of Microbiology & Immunology, Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA
| | - Ian N Clarke
- Molecular Microbiology Group, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK
| |
Collapse
|
6
|
Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis. PLoS One 2016; 11:e0149011. [PMID: 26871455 PMCID: PMC4752267 DOI: 10.1371/journal.pone.0149011] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Accepted: 01/26/2016] [Indexed: 12/24/2022] Open
Abstract
The obligate intracellular developmental cycle of Chlamydia trachomatis presents significant challenges in defining its proteome. In this study we have applied quantitative proteomics to both the intracellular reticulate body (RB) and the extracellular elementary body (EB) from C. trachomatis. We used C. trachomatis L2 as a model chlamydial isolate for our study since it has a high infectivity:particle ratio and there is an excellent quality genome sequence. EBs and RBs (>99% pure) were quantified by chromosomal and plasmid copy number using PCR, from which the concentrations of chlamydial proteins per bacterial cell/genome were determined. RBs harvested at 15h post infection (PI) were purified by three successive rounds of gradient centrifugation. This is the earliest possible time to obtain purified RBs, free from host cell components in quantity, within the constraints of the technology. EBs were purified at 48h PI. We then used two-dimensional reverse phase UPLC to fractionate RB or EB peptides before mass spectroscopic analysis, providing absolute amount estimates of chlamydial proteins. The ability to express the data as molecules per cell gave ranking in both abundance and energy requirements for synthesis, allowing meaningful identification of rate-limiting components. The study assigned 562 proteins with high confidence and provided absolute estimates of protein concentration for 489 proteins. Interestingly, the data showed an increase in TTS capacity at 15h PI. Most of the enzymes involved in peptidoglycan biosynthesis were detected along with high levels of muramidase (in EBs) suggesting breakdown of peptidoglycan occurs in the non-dividing form of the microorganism. All the genome-encoded enzymes for glycolysis, pentose phosphate pathway and tricarboxylic acid cycle were identified and quantified; these data supported the observation that the EB is metabolically active. The availability of detailed, accurate quantitative proteomic data will be invaluable for investigations into gene regulation and function.
Collapse
|
7
|
Śliwa-Dominiak J, Suszyńska E, Pawlikowska M, Deptuła W. Chlamydia bacteriophages. Arch Microbiol 2013; 195:765-71. [DOI: 10.1007/s00203-013-0912-8] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2013] [Revised: 07/08/2013] [Accepted: 07/09/2013] [Indexed: 10/26/2022]
|
8
|
O’Neill CE, Seth-Smith HMB, Van Der Pol B, Harris SR, Thomson NR, Cutcliffe LT, Clarke IN. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. Microbiology (Reading) 2013; 159:748-756. [DOI: 10.1099/mic.0.065391-0] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Affiliation(s)
- C. E. O’Neill
- Faculty of Medicine, CES Academic Unit, Level C, South Block, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK
| | - H. M. B. Seth-Smith
- The Wellcome Trust Sanger Institute, Pathogen Genomics, Hinxton, Cambridge, UK
| | - B. Van Der Pol
- Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA
| | - S. R. Harris
- The Wellcome Trust Sanger Institute, Pathogen Genomics, Hinxton, Cambridge, UK
| | - N. R. Thomson
- The Wellcome Trust Sanger Institute, Pathogen Genomics, Hinxton, Cambridge, UK
| | - L. T. Cutcliffe
- Faculty of Medicine, CES Academic Unit, Level C, South Block, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK
| | - I. N. Clarke
- Faculty of Medicine, CES Academic Unit, Level C, South Block, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, UK
| |
Collapse
|
9
|
Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Persson K, Bjartling C, Clarke IN. Genetic transformation of a clinical (genital tract), plasmid-free isolate of Chlamydia trachomatis: engineering the plasmid as a cloning vector. PLoS One 2013; 8:e59195. [PMID: 23527131 PMCID: PMC3601068 DOI: 10.1371/journal.pone.0059195] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2012] [Accepted: 02/11/2013] [Indexed: 11/18/2022] Open
Abstract
Our study had three objectives: to extend the plasmid-based transformation protocol to a clinical isolate of C. trachomatis belonging to the trachoma biovar, to provide “proof of principle” that it is possible to “knock out” selected plasmid genes (retaining a replication competent plasmid) and to investigate the plasticity of the plasmid. A recently developed, plasmid-based transformation protocol for LGV isolates of C. trachomatis was modified and a plasmid-free, genital tract C. trachomatis isolate from Sweden (SWFP-) was genetically transformed. Transformation of this non-LGV C. trachomatis host required a centrifugation step, but the absence of the natural plasmid removed the need for plaque purification of transformants. Transformants expressed GFP, were penicillin resistant and iodine stain positive for accumulated glycogen. The transforming plasmid did not recombine with the host chromosome. A derivative of pGFP::SW2 carrying a deletion of the plasmid CDS5 gene was engineered. CDS5 encodes pgp3, a protein secreted from the inclusion into the cell cytoplasm. This plasmid (pCDS5KO) was used to transform C. trachomatis SWFP-, and established that pgp3 is dispensable for plasmid function. The work shows it is possible to selectively delete segments of the chlamydial plasmid, and this is the first step towards a detailed molecular dissection of the role of the plasmid. The 3.6 kb β-galactosidase cassette was inserted into the deletion site of CDS5 to produce plasmid placZ-CDS5KO. Transformants were penicillin resistant, expressed GFP and stained for glycogen. In addition, they expressed β-galactosidase showing that the lacZ cassette was functional in C. trachomatis. An assay was developed that allowed the visualisation of individual inclusions by X-gal staining. The ability to express active β-galactosidase within chlamydial inclusions is an important advance as it allows simple, rapid assays to measure directly chlamydial infectivity without the need for plaquing, fluorescence or antibody staining.
Collapse
Affiliation(s)
- Yibing Wang
- Molecular Microbiology Group, University of Southampton, Southampton, United Kingdom
| | - Simona Kahane
- Department of Virology, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - Lesley T. Cutcliffe
- Molecular Microbiology Group, University of Southampton, Southampton, United Kingdom
| | - Rachel J. Skilton
- Molecular Microbiology Group, University of Southampton, Southampton, United Kingdom
| | - Paul R. Lambden
- Molecular Microbiology Group, University of Southampton, Southampton, United Kingdom
| | - Kenneth Persson
- Department of Laboratory Medicine, Malmo University Hospital, Malmo, Sweden
| | - Carina Bjartling
- Department of Obstetrics and Gynaecology, Malmo University Hospital, Malmo, Sweden
| | - Ian N. Clarke
- Molecular Microbiology Group, University of Southampton, Southampton, United Kingdom
- * E-mail:
| |
Collapse
|
10
|
Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Clarke IN. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog 2011; 7:e1002258. [PMID: 21966270 PMCID: PMC3178582 DOI: 10.1371/journal.ppat.1002258] [Citation(s) in RCA: 284] [Impact Index Per Article: 21.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2011] [Accepted: 07/26/2011] [Indexed: 01/23/2023] Open
Abstract
Chlamydia trachomatis remains one of the few major human pathogens for which there is no transformation system. C. trachomatis has a unique obligate intracellular developmental cycle. The extracellular infectious elementary body (EB) is an infectious, electron-dense structure that, following host cell infection, differentiates into a non-infectious replicative form known as a reticulate body (RB). Host cells infected by C. trachomatis that are treated with penicillin are not lysed because this antibiotic prevents the maturation of RBs into EBs. Instead the RBs fail to divide although DNA replication continues. We have exploited these observations to develop a transformation protocol based on expression of β-lactamase that utilizes rescue from the penicillin-induced phenotype. We constructed a vector which carries both the chlamydial endogenous plasmid and an E.coli plasmid origin of replication so that it can shuttle between these two bacterial recipients. The vector, when introduced into C. trachomatis L2 under selection conditions, cures the endogenous chlamydial plasmid. We have shown that foreign promoters operate in vivo in C. trachomatis and that active β-lactamase and chloramphenicol acetyl transferase are expressed. To demonstrate the technology we have isolated chlamydial transformants that express the green fluorescent protein (GFP). As proof of principle, we have shown that manipulation of chlamydial biochemistry is possible by transformation of a plasmid-free C. trachomatis recipient strain. The acquisition of the plasmid restores the ability of the plasmid-free C. trachomatis to synthesise and accumulate glycogen within inclusions. These findings pave the way for a comprehensive genetic study on chlamydial gene function that has hitherto not been possible. Application of this technology avoids the use of therapeutic antibiotics and therefore the procedures do not require high level containment and will allow the analysis of genome function by complementation.
Collapse
Affiliation(s)
- Yibing Wang
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Simona Kahane
- Department of Virology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - Lesley T. Cutcliffe
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Rachel J. Skilton
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Paul R. Lambden
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Ian N. Clarke
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| |
Collapse
|
11
|
Skilton RJ, Cutcliffe LT, Barlow D, Wang Y, Salim O, Lambden PR, Clarke IN. Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle. PLoS One 2009; 4:e7723. [PMID: 19893744 PMCID: PMC2769264 DOI: 10.1371/journal.pone.0007723] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2009] [Accepted: 10/09/2009] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND Chlamydia trachomatis is a major human pathogen with a unique obligate intracellular developmental cycle that takes place inside a modified cytoplasmic structure known as an inclusion. Following entry into a cell, the infectious elementary body (EB) differentiates into a non-infectious replicative form known as a reticulate body (RB). RBs divide by binary fission and at the end of the cycle they redifferentiate into EBs. Treatment of C.trachomatis with penicillin prevents maturation of RBs which survive and enlarge to become aberrant RBs within the inclusion in a non-infective persistent state. Persistently infected individuals may be a reservoir for chlamydial infection. The C.trachomatis genome encodes the enzymes for peptidoglycan (PG) biosynthesis but a PG sacculus has never been detected. This coupled to the action of penicillin is known as the chlamydial anomaly. We have applied video microscopy and quantitative DNA assays to the chlamydial developmental cycle to assess the effects of penicillin treatment and establish a framework for investigating penicillin induced chlamydial persistence. PRINCIPAL FINDINGS Addition of penicillin at the time of cell infection does not prevent uptake and the establishment of an inclusion. EB to RB transition occurs but bacterial cytokinesis is arrested by the second binary fission. RBs continue to enlarge but not divide in the presence of penicillin. The normal developmental cycle can be recovered by the removal of penicillin although the large, aberrant RBs do not revert to the normal smaller size but remain present to the completion of the developmental cycle. Chromosomal and plasmid DNA replication is unaffected by the addition of penicillin but the arrest of bacterial cytokinesis under these conditions results in RBs accumulating multiple copies of the genome. CONCLUSIONS We have applied video time lapse microscopy to the study of the chlamydial developmental cycle. Linked with accurate measures of genome replication this provides a defined framework to analyse the developmental cycle and to investigate and provide new insights into the effects of antibiotic treatments. Removal of penicillin allows recovery of the normal developmental cycle by 10-20 hrs and the process occurs by budding from aberrant RBs.
Collapse
Affiliation(s)
- Rachel J. Skilton
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Lesley T. Cutcliffe
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - David Barlow
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Yibing Wang
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Omar Salim
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Paul R. Lambden
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
| | - Ian N. Clarke
- Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, Southampton, United Kingdom
- * E-mail:
| |
Collapse
|
12
|
Salim O, Skilton RJ, Lambden PR, Fane BA, Clarke IN. Behind the chlamydial cloak: The replication cycle of chlamydiaphage Chp2, revealed. Virology 2008; 377:440-5. [DOI: 10.1016/j.virol.2008.05.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2008] [Revised: 04/16/2008] [Accepted: 05/01/2008] [Indexed: 11/30/2022]
|